Semaglutide May Be Useful in Reducing Dry Macular Degeneration and Glaucoma

 A recent study published in Ophthalmology demonstrated GLP-1 receptor agonists were associated with reduced hazard of nonexudative AMD. Notably, GLP-1 receptor agonists also significantly reduced the risk of exudative AMD and POAG compared to insulin after three years.

“The consistency of these findings across multiple comparisons suggests a potential benefit of GLP-1RAs in mitigating the risk of nonexudative AMD,” the researchers wrote in their paper. “Demonstrating a reduction in risk of POAG without a significant impact on the rate of ocular hypertension could indicate the protective effect is separate from lowering intraocular pressure.”



Comments

Popular posts from this blog

IMPLANTABLE COLLAMER LENS APPEARS BETTER THAN LASIK OR PRK FOR MODERATE TO HIGH MYOPIC PATIENTS

RINSING YOUR CONTACT LENS CASE IS NOT ENOUGH